Global Sequencing Approach for Characterizing the Molecular Background of Hereditary Iron Disorders (Molecular Diagnostics and Genetics) Global Sequencing Approach for Characterizing the Molecular Background of Hereditary Iron Disorders (Molecular Diagnostics and Genetics)

Global Sequencing Approach for Characterizing the Molecular Background of Hereditary Iron Disorders (Molecular Diagnostics and Genetics‪)‬

Clinical Chemistry 2007, Dec, 53, 12

    • $5.99
    • $5.99

Publisher Description

Hereditary hemochromatosis (HH) [9] is the main cause of inherited iron overload. When present in a homozygous state, the Cys282Tyr mutation in the hemochromatosis (HFE) [10] gene product is the most common genetic background of HH (1). Ten years after the description of this genotype, further investigations of the disease have revealed considerable heterogeneity. First, other HFE genotypes, including the compound heterozygote encoding the Cys282Tyr and His63Asp mutations, have been associated with an HH phenotype, although individuals with such genotypes accumulate less iron than Cys282Tyr homozygotes (1-3). Other rare private HFE mutations responsible for HH have also been reported. Second, Cys282Tyr homozygotes have been demonstrated to lack full penetrance (4), and some individuals homozygous for the Cys282Tyr mutant remain asymptomatic throughout life. Investigators have also described several other genes that present a phenotype similar to that of HFE-related HH, indicating that hemochromatosis is a multigene disorder. Nowadays, HH is considered an autosomal-recessive inherited disorder with 2 clinical forms, adult and juvenile HH (5, 6), defined according to the age of onset. Juvenile hemochromatosis (JH) is due to a mutation in 1 of 2 genes: HFE2 [hemochromatosis type 2 (juvenile); also known as HJV and encoding hemojuvelin] (7) and, more rarely, HAMP (hepcidin antimicrobial peptide) (8). Adult HH is mainly due to mutation in HFE, and TFR2 (transferrin receptor 2) mutations are rarely found (9). Associations between mutations of different genes leading to modified clinical presentations have been described for some patients. Such findings demonstrate that hemochromatosis can be a multigenic or at least a digenic disease. Indeed, HAMP (10), HFE2 (11), or TFR2 (12) mutations that have been associated with HFE genotypes have been described to aggravate the clinical presentation.

GENRE
Science & Nature
RELEASED
2007
1 December
LANGUAGE
EN
English
LENGTH
25
Pages
PUBLISHER
American Association for Clinical Chemistry, Inc.
SELLER
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
SIZE
235.2
KB
Characterization of Publicly Available Lymphoblastoid Cell Lines for Disease-Associated Mutations in 11 Genes (Technical Briefs) Characterization of Publicly Available Lymphoblastoid Cell Lines for Disease-Associated Mutations in 11 Genes (Technical Briefs)
2005
Heterozygosity for the C282Y Mutation in the Hemochromatosis Gene is Associated with Increased Serum Iron, Transferrin Saturation, And Hemoglobin in Young Women: A Protective Role Against Iron Deficiency?(Molecular Diagnostics and Genetics) Heterozygosity for the C282Y Mutation in the Hemochromatosis Gene is Associated with Increased Serum Iron, Transferrin Saturation, And Hemoglobin in Young Women: A Protective Role Against Iron Deficiency?(Molecular Diagnostics and Genetics)
1998
Microarray Technology and Applications in the Arena of Genome-Wide Association. Microarray Technology and Applications in the Arena of Genome-Wide Association.
2008
Clinical Applications for Next-Generation Sequencing Clinical Applications for Next-Generation Sequencing
2015
Principles and Applications of Molecular Diagnostics Principles and Applications of Molecular Diagnostics
2018
Translational Cardiometabolic Genomic Medicine Translational Cardiometabolic Genomic Medicine
2015
Lowering Cutoffs for Initial and Confirmation Testing for Cocaine and Marijuana: Large-Scale Study of Effects on the Rates of Drug-Positive Results (Drug Monitoring and Toxicology) Lowering Cutoffs for Initial and Confirmation Testing for Cocaine and Marijuana: Large-Scale Study of Effects on the Rates of Drug-Positive Results (Drug Monitoring and Toxicology)
1997
Myocardial Infarction Redefined: Role of Cardiac Troponin Testing (Editorial) Myocardial Infarction Redefined: Role of Cardiac Troponin Testing (Editorial)
2001
Distribution of Fasting Plasma Insulin, Free Fatty Acids, And Glucose Concentrations and of Homeostasis Model Assessment of Insulin Resistance in a Representative Sample of Quebec Children and Adolescents (Pediatric Clinical Chemistry) Distribution of Fasting Plasma Insulin, Free Fatty Acids, And Glucose Concentrations and of Homeostasis Model Assessment of Insulin Resistance in a Representative Sample of Quebec Children and Adolescents (Pediatric Clinical Chemistry)
2003
C677T and AI298C Polymorphisms of the Methylenetetrahydrofolate Reductase Gene: Incidence and Effect of Combined Genotypes on Plasma Fasting and Post-Methionine Load Homocysteine in Vascular Disease (Molecular Diagnostics and Genetics) C677T and AI298C Polymorphisms of the Methylenetetrahydrofolate Reductase Gene: Incidence and Effect of Combined Genotypes on Plasma Fasting and Post-Methionine Load Homocysteine in Vascular Disease (Molecular Diagnostics and Genetics)
2001
Acetylcholinesterase Activity and Biogenic Amines in Phenylketonuria (Technical Briefs) Acetylcholinesterase Activity and Biogenic Amines in Phenylketonuria (Technical Briefs)
2002
Homocysteine, 5, 10-Methylenetetrahydrofolate Reductase 677CT Polymorphism, Nutrient Intake, And Incident Cardiovascular Disease in 24 968 Initially Healthy Women (Molecular Diagnostics and Genetics) (Clinical Report) Homocysteine, 5, 10-Methylenetetrahydrofolate Reductase 677CT Polymorphism, Nutrient Intake, And Incident Cardiovascular Disease in 24 968 Initially Healthy Women (Molecular Diagnostics and Genetics) (Clinical Report)
2007